rheumatology
Rheumatoid arthritis

Baricitinib now on PBS for RA

The JAK inhibitor baricitinib (Olumiant) has been listed on the PBS from 1 September for patients with rheumatoid arthritis (RA). The once daily tablet drug is available as an Authority required item for adult patients with moderate to severe active RA who have responded inadequately, or who are intolerant, to one or more DMARDs. The ...

Already a member?

Login to keep reading.


OR
© 2021 the limbic